Key result
Mechanical-optical ACT systems read ~57 seconds higher than microfluidic systems during DOAC-treated transseptal ablation.
Why the study?
Different point-of-care activated clotting time (ACT) systems with distinct analytical principles are used interchangeably during transseptal ablation despite potential non-equivalent values.
Does the choice of point-of-care ACT measurement system affect recorded values and target attainment in patients undergoing transseptal ablation on uninterrupted DOAC therapy?
Observational (n=30)
Does the choice of point-of-care ACT measurement system affect recorded values and target attainment in patients undergoing transseptal ablation on uninterrupted DOAC therapy?
Different point-of-care ACT systems yield significantly different values with a positive offset of ~50-60 seconds for mechanical-optical systems, indicating that uniform guideline-recommended ACT cutoffs may misclassify anticoagulation adequacy.
Answers are grounded in this paper and cite their sources.
Device bias risks inconsistent anticoagulation decisions during ablation; challenges uniform thresholds and leaves standardization needs open.
Background Monitoring activated clotting time (ACT) is essential during transseptal ablation. Despite having distinct analytical principles and potentially non-equivalent values, different point-of-care ACT systems are used interchangeably. Objective This study aimed to compare ACT values from a mechanical-optical and a microfluidic electrochemical system in patients treated with direct oral anticoagulant (DOAC) undergoing transseptal ablation and to quantify the impact of device-related bias on guideline-recommended ACT targets. Methods 30 consecutive patients undergoing left-sided transseptal catheter ablation under uninterrupted DOAC therapy were studied. After transseptal puncture, unfractionated heparin was administered, and ACT was measured simultaneously with both systems at predefined time points. The primary analysis included 42 paired post-heparin measurements; a complementary analysis included all 55 paired measurements (pre- and post-heparin). Agreement was assessed using paired t -tests, linear regression, and Bland–Altman analysis. Thresholds of ≥250 seconds and ≥300 seconds were evaluated. Results In the primary post-heparin analysis, mean ACT was 316.3 ± 51.5 seconds with the mechanical-optical system and 259.3 ± 29.8 seconds with the microfluidic system, yielding a mean bias of 57.0 seconds (95% confidence interval, 41.7–72.3; P < .001). Including all 55 measurements, the mean bias remained large at 48.4 seconds with strong per-measurement correlation. Using a threshold of ≥250 seconds, 90.0% vs 46.6% of measurements met the target; at ≥300 seconds, 60.0% vs 10.0%. Conclusion Mechanical-optical and microfluidic electrochemical ACT systems show a consistent positive offset of roughly 50–60 seconds. Uniform ACT cutoffs across devices may misclassify anticoagulation adequacy, supporting device- and cartridge-specific ACT targets during DOAC-treated transseptal ablation.
No takes yet. Share an insight, caveat, or question.
Krieger et al. (2026) conducted an observational in Patients treated with DOACs undergoing transseptal ablation (n=30). Mechanical-optical ACT system vs. Microfluidic electrochemical ACT system was evaluated on Mean bias between systems in post-heparin ACT measurements (Mean bias 57.0 seconds, 95% CI 41.7-72.3, p=<.001). Mechanical-optical ACT systems showed a mean positive bias of 57.0 seconds compared to microfluidic electrochemical systems during DOAC-treated transseptal ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: